yeah agree with the sentiment. If Neuren partnered with a global pharmaceutical company as opposed to Acadia, we may not have gotten to where we are and the progress would have stalled during Covid. Right now, Trofinetide is Acadia’s only lifeline and they are throwing everything at it and it makes a difference.
- Forums
- ASX - By Stock
- Updated MST report - target of $3.68 a share
yeah agree with the sentiment. If Neuren partnered with a global...
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$16.15 |
Change
-0.940(5.50%) |
Mkt cap ! $2.064B |
Open | High | Low | Value | Volume |
$15.04 | $16.33 | $14.65 | $25.91M | 1.638M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 125 | $16.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.20 | 1500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 125 | 16.150 |
1 | 650 | 16.110 |
1 | 500 | 16.100 |
2 | 510 | 16.050 |
1 | 662 | 16.040 |
Price($) | Vol. | No. |
---|---|---|
16.200 | 1500 | 1 |
16.290 | 10000 | 1 |
16.500 | 1250 | 2 |
16.600 | 100 | 1 |
16.750 | 1000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |